The NAP Evidence Compendium

The Universal Peer Reviewed Research Foundation of

Nutraceutical Assisted Programs Companion Document to The NAP Manifesto A Living Research Reference for the Global Category Michael Andrew Feller Jones Founder, Nutraceutical Assisted Programs Category Inaugural Chair, NAP Standards Council

---

EXECUTIVE SUMMARY

The Question This Compendium Answers

Is the clinical paradigm presented in The NAP Manifesto, including the Eight Universal Biological Systems framework, the Seven Foundational Dysfunction Categories, the cascade architecture of chronic disease, and the diagnostic inversion methodology, supported by peer reviewed scientific research? This document answers that question system by system, dysfunction by dysfunction, claim by claim. The answer, across the substantial majority of the framework, is yes.

What This Compendium Establishes

Every day, populations across the developed and developing world face a chronic disease crisis that the dominant pharmaceutical paradigm has not solved and cannot solve within the limits of its current architecture. The peer reviewed research synthesized in this compendium establishes that this crisis is real, that it has identifiable biological mechanisms, that those mechanisms are addressable through systematic restoration of foundational biological systems, and that the framework presented in The NAP Manifesto reflects the convergence of multiple independent research streams toward an integrated understanding of human health and disease. The core claims of the NAP framework are supported by the following established research findings. The eight biological systems identified as foundational in the NAP framework are documented in peer reviewed literature as the integrated functional domains through which the human body maintains health. Dysfunction in each system is associated with specific clinical manifestations across multiple disease categories, supporting the systems based diagnostic approach. The seven dysfunction categories identified as the pathology framework are each supported by independent bodies of peer reviewed research demonstrating their mechanisms, their clinical manifestations, and their interaction with each other in producing chronic disease. Toxic burden, nutrient depletion, microbial imbalance, hormonal dysregulation, inflammatory cascade, energetic dysfunction, and immune incompetence are not theoretical constructs. They are documented biological realities affecting the modern global population. The cascade architecture of chronic disease, in which dysfunction in one biological system propagates through the integrated network to produce dysfunction in other systems, is supported by mechanism level research across multiple disciplines including systems biology, integrative medicine, environmental medicine, and functional medicine. While integrated tests of the full cascade hypothesis remain limited, the individual mechanistic links are well documented.

The Developmental Origins of Health and Disease research framework, established through the Barker hypothesis and validated through decades of peer reviewed research, demonstrates that adult chronic disease frequently originates in prenatal, perinatal, and early childhood exposures and developmental conditions. This research validates the NAP framework's lifespan trajectory perspective and supports the preventive medicine emphasis that distinguishes NAP from purely reactive disease management.

Cumulative exposure research demonstrates that real world human chemical and stressor exposure is multifactorial rather than single substance, that combined exposures can produce synergistic rather than merely additive effects, and that the regulatory paradigm of single substance assessment systematically underestimates real world health risk. This research supports the NAP framework's emphasis on comprehensive terrain assessment and integrated intervention rather than single agent pharmaceutical management.

Convergence across multiple independent medical and scientific disciplines, including environmental medicine, functional medicine, integrative psychiatry, systems biology, and modern clinical nutrition, supports the foundational claim that chronic disease is a multifactorial, terrain driven, and integrated phenomenon that requires the unified clinical paradigm that NAP provides.

What This Compendium Qualifies

The NAP framework is strongest when it is honest about the limits of current evidence. Several claims in the framework require careful calibration against what the research currently supports.

The integrated cascade architecture, in which all eight biological systems and all seven dysfunction categories interact as a unified clinical system in any individual patient, is supported by the individual links between systems and dysfunctions but has not been comprehensively tested as a unified clinical hypothesis in large prospective trials. This is acknowledged as a research priority for the NAP Standards Council.

The clinical effectiveness of comprehensive multi-domain NAP protocols compared to single intervention approaches is supported by emerging integrative medicine research but lacks the volume of large randomized controlled trials that characterizes pharmaceutical intervention research. Prospective NAP outcome data collection across accredited centers is the priority research program for establishing this evidence base.

Specific botanical and nutraceutical protocols for specific clinical conditions vary in evidence strength from well established to emerging to traditional knowledge based. The condition specific protocols in the NAP Standards Library will be supported by their own evidence appendices that classify each component by evidence strength, allowing transparent practitioner and patient understanding of the foundation for each clinical recommendation.

What This Compendium Commits To

This document is a living reference. The NAP Standards Council commits to maintaining it under the following principles. Every specific factual claim in The NAP Manifesto traces to a cited source in this compendium or in the supporting protocol evidence appendices. Where no peer reviewed source is available, the claim is identified as emerging, traditional, or requiring additional research, rather than presented as established. Evidence is classified by strength level. STRONG indicates multiple peer reviewed sources from independent research groups with consistent findings. MODERATE indicates peer reviewed sources with emerging consensus. EMERGING indicates early or limited peer reviewed work with promising preliminary findings. CALIBRATION indicates claims that require updating or qualification from forms in which they sometimes appear in advocacy or popular discussion. Citations link to original peer reviewed sources where available. Source metadata is provided to allow independent verification. The compendium is updated as new research emerges and as the NAP research program generates its own outcome data.

"NAP is offered to the world as a public good. The evidence supporting NAP is offered with the same standard of intellectual honesty. Every claim is either supported by published research or transparently qualified. The credibility of the category depends on this commitment."

METHODOLOGY AND SCOPE

How This Compendium Was Assembled

The Evidence Compendium was assembled by identifying every specific factual claim and clinical mechanism described in The NAP Manifesto and conducting targeted literature review for peer reviewed sources supporting or qualifying each. Search was conducted across PubMed, PMC, major clinical journals including Nature Medicine, Lancet, JAMA, Environmental Health Perspectives, Journal of Clinical Endocrinology and Metabolism, and relevant integrative and functional medicine literature. Where claims relied on traditional medicine sources, those sources are identified as such with appropriate context for the role traditional knowledge plays alongside peer reviewed research.

Evidence Classification System

Each research territory and clinical claim is classified by the strength of available evidence.

STRONG Evidence

Multiple peer reviewed sources from independent research groups, published in recognized clinical or scientific journals, showing consistent findings across populations and contexts. This classification applies to fundamental mechanisms of human biology that underlie the eight systems framework, the documented effects of environmental toxin exposure across populations, the role of essential nutrients in maintaining biological function, the developmental origins of adult disease, and the principle of integrated systems function in human health.

MODERATE Evidence

Peer reviewed sources exist with consistent findings but evidence is based on smaller cohorts, specific populations, or is still emerging toward broader consensus. This classification applies to specific clinical applications of foundational principles, to integrative medicine outcomes research that is growing but still smaller in scale than pharmaceutical research, and to specific nutraceutical and botanical interventions where mechanism is established but large clinical trials are limited.

EMERGING Evidence

Limited peer reviewed work, early observational studies, or research that is primarily theoretical or mechanistic with limited clinical validation. This classification applies to integrated cascade hypotheses, specific newer nutraceutical compounds, and some applications of traditional knowledge to modern clinical practice.

CALIBRATION Notation

Claims that have circulated in public discussion or advocacy but that require updating or qualification based on what the current peer reviewed literature actually supports. The category exists to ensure intellectual honesty about specific quantitative or descriptive claims that may have drifted from their original peer reviewed sources during transmission through popular media.

Scope and Application

This compendium covers the universal foundational research that supports the NAP framework as it applies to all human populations across the lifespan and across geographic, cultural, and demographic contexts. Population specific applications, including the application of NAP principles to specific demographic groups, occupational exposures, life stage transitions, and condition specific clinical territories, are addressed in separate evidence appendices that complement this foundational document. The clinical territory specific evidence will be developed as the NAP Standards Library matures and as accredited NAP Centers contribute outcome data to the unified research framework.

TERRITORY ONE: SYSTEMS BIOLOGY AND INTEGRATED HUMAN FUNCTION

Research Question

Is the human body accurately understood as an integrated system of interconnected biological domains, and does this integrated systems perspective produce clinical insight that single organ or single condition perspectives cannot?

Evidence Summary

[STRONG] The human body operates as an integrated system in which every organ and tissue communicates with every other through documented biological pathways. The systems biology literature has established over the past three decades that the historical model of separate organ systems with limited intercommunication does not reflect biological reality. Documented integrative networks include the gut brain axis through neural, endocrine, and immune signaling. The neuroendocrine immune network coordinating stress response, immune function, and behavior. The metabolic regulatory network linking energy homeostasis across multiple organ systems. The microbiome host signaling network through which trillions of microbial cells affect host metabolism, immunity, and neurological function. These networks are not theoretical constructs. They are documented biological realities supported by extensive peer reviewed research.

Cryan JF, et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews. Foundational review of gut brain axis integration. Mayer EA, et al. (2014). Gut microbes and the brain: paradigm shift in neuroscience. Journal of Neuroscience. Reichlin S (1993). Neuroendocrine-immune interactions. New England Journal of Medicine. Classical review establishing the integrated regulatory framework.

[STRONG] Chronic disease in modern populations is multifactorial and emerges from the interaction of multiple dysfunctional biological systems rather than from single organ pathology. Modern medical research has documented that the major chronic disease categories driving morbidity and mortality in developed populations are multifactorial in origin. Cardiovascular disease emerges from the interaction of inflammatory, metabolic, hormonal, microbial, and structural factors. Type 2 diabetes emerges from metabolic dysfunction interacting with inflammation, microbial imbalance, hormonal dysregulation, and lifestyle factors. Neurodegenerative disease emerges from the interaction of vascular, inflammatory, metabolic, toxic, and genetic factors. Autoimmune disease emerges from the interaction of microbial, inflammatory, environmental, and genetic factors. The single pathway pharmaceutical model cannot adequately address conditions that arise from multifactorial interaction across multiple systems.

Hotamisligil GS (2017). Inflammation, metaflammation and immunometabolic disorders. Nature. Foundational review establishing the integrated nature of metabolic and inflammatory disease. Heneka MT, et al. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology. Establishes integration of inflammatory, vascular, and neurodegenerative mechanisms.

[STRONG] Functional medicine and systems biology have converged toward a clinical paradigm that addresses the integrated nature of human function and chronic disease. The Institute for Functional Medicine and broader functional medicine movement, developed since the 1990s, has established a clinical framework that addresses the integrated systems nature of chronic disease through comprehensive assessment and protocol design. The systems biology research community has produced parallel scientific frameworks emphasizing network analysis of biological function. These movements have converged toward an integrated understanding that closely parallels the framework presented in The NAP Manifesto. The convergence supports the NAP claim that the integrated systems perspective is not a fringe approach but represents the direction toward which the most advanced clinical and scientific thinking is moving.

Hyman M (2018). Functional medicine: an operating system for integrative health. Journal of the American Medical Association. Editorial perspective on the convergence. Bland JS (2017). Functional Medicine Past, Present, and Future. Integrative Medicine Clinician's Journal. Historical and conceptual development.

[STRONG] Chronic disease in modern populations is predominantly multimorbid rather than single condition, supporting a systems based rather than single disease clinical model. Large population studies document that the majority of people with a chronic condition have more than one, that multimorbidity rises steeply with age and socioeconomic deprivation, and that within large health systems a minority of patients carrying multiple chronic conditions account for a majority of total cost. This is the epidemiological signature that the systems based NAP framework is built to address. CALIBRATION: the precise prevalence and cost concentration figures vary by population and health system; the consistent, directional finding across studies is that chronic disease clusters within individuals rather than occurring in isolation.

Barnett K, et al. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education. Lancet. Yoon J, et al. (2014). Recent trends in Veterans Affairs chronic condition spending. Medical Care.

[MODERATE] Cumulative physiological stress load produces measurable multi system wear, providing a mechanistic bridge between chronic stress and integrated organ system decline. The allostatic load framework describes how repeated or sustained activation of the stress response systems produces cumulative dysregulation across the neurological, endocrine, immune, cardiovascular, and metabolic systems, consistent with the cascade architecture the framework describes.

McEwen BS (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine.

Clinical Significance for the NAP Framework

The systems biology evidence establishes the foundational scientific basis for the eight systems framework that organizes NAP clinical practice. Treating the patient as an integrated system rather than as a collection of separate symptoms is not a philosophical preference. It is a clinical methodology aligned with the actual biology of human function and chronic disease. The NAP framework operationalizes this integrated systems perspective through standardized assessment, protocol design, and outcome measurement that captures the multifactorial nature of clinical presentations.

TERRITORY TWO: DETOXIFICATION AND ENVIRONMENTAL TOXIN BURDEN

Research Question

Does the modern human population face documented environmental toxin exposure that exceeds historical baselines, and do these exposures produce measurable health consequences across systems?

Evidence Summary

[STRONG] Modern populations carry measurable body burdens of multiple synthetic chemicals that did not exist in human biology a century ago. Biomonitoring research conducted by the Centers for Disease Control and Prevention through the National Report on Human Exposure to Environmental Chemicals, by similar programs in the European Union, Canada, and other developed nations, has documented that the general adult population carries detectable body burdens of phthalates, polybrominated diphenyl ethers, perfluorinated compounds, bisphenol A and related compounds, organochlorine pesticide residues, polychlorinated biphenyls, multiple heavy metals, and dozens of other synthetic chemicals. The burden begins prenatally, with cord blood biomonitoring detecting hundreds of synthetic chemicals in newborns. The burden persists across the lifespan, accumulating in lipid rich tissues including brain, adipose tissue, and bone.

CDC National Center for Environmental Health. National Report on Human Exposure to Environmental Chemicals. Updated periodic reports. Environmental Working Group (2005). Body Burden: The Pollution in Newborns. Cord blood biomonitoring. Woodruff TJ, et al. (2011). Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environmental Health Perspectives.

[STRONG] Environmental toxin exposure is associated with increased risk of multiple chronic disease categories. Peer reviewed research has established associations between environmental toxin exposure and cardiovascular disease, type 2 diabetes, neurodevelopmental disorders, neurodegenerative disease, multiple cancers, hormonal dysregulation, reproductive dysfunction, autoimmune disease, and metabolic syndrome. The associations are documented across multiple toxin categories including heavy metals, persistent organic pollutants, endocrine disrupting chemicals, air pollution components, and pesticide residues. The evidence is sufficient that international expert bodies including the World Health Organization Endocrine Society, and major professional medical organizations have issued statements acknowledging environmental toxin exposure as a substantial contributor to global chronic disease burden.

Gore AC, et al. (2015). EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews.

Landrigan PJ, et al. (2018). The Lancet Commission on pollution and health. Lancet. Established global pollution mortality estimates.

Trasande L, et al. (2015). Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. Journal of Clinical Endocrinology and Metabolism.

[STRONG] Heavy metal exposure produces documented neurotoxic effects through multiple mechanisms applicable across all populations. Peer reviewed research spanning decades has established that lead, mercury, arsenic, cadmium, aluminum, and related heavy metals produce neurological and behavioral effects in humans through multiple documented mechanisms. These mechanisms include direct neuronal damage, oxidative stress, inflammatory activation, neurotransmitter system disruption particularly affecting dopaminergic and serotonergic signaling, mitochondrial dysfunction, and disruption of dendritic spine dynamics in brain regions critical for executive function and emotional regulation. These effects are documented in adult and developing populations, in occupational and environmental exposure contexts, and across geographic and demographic boundaries.

Sanders T, et al. Metal toxicity in the central nervous system. Environmental Health Perspectives. Foundational review of mechanisms. PMC1474439.

Exposure to heavy metals and neurocognitive function in adults: a systematic review (2024). Environmental Sciences Europe.

Co-exposure to lead, mercury, and cadmium induces neurobehavioral impairments via dopaminergic and serotonergic disruption (2023). Frontiers in Public Health.

[STRONG] Cumulative chemical exposure produces effects that exceed those predicted by single substance assessment. The peer reviewed cumulative risk assessment literature has documented that human populations face simultaneous exposure to thousands of synthetic chemicals through air, water, food, and consumer products. The interactions among these exposures can produce synergistic effects exceeding the sum of individual substance effects. This finding has substantial regulatory and clinical implications because the dominant single substance regulatory framework systematically underestimates real world health risk. The European Union, World Health Organization, and emerging United States regulatory frameworks are gradually adapting to incorporate cumulative risk assessment. The clinical implication for NAP is that comprehensive terrain assessment, addressing the totality of exposure burden rather than isolated substances, more accurately reflects biological reality than single agent intervention.

Sexton K, Hattis D (2007). Assessing cumulative health risks from exposure to environmental mixtures. Environmental Health Perspectives. PMC1867955.

Mixture toxicity revisited: A translational review of experimental evidence (2025). Toxicology. Recent comprehensive review. Cumulative Risk Assessment: An Overview of Methodological Approaches (2012). PMC3315252. Cumulative Health Risk from Exposure Load (CHREL) (2024). PubMed PMID 39341379.

[MODERATE] Long term exposure to chlorinated industrial solvents is associated with elevated risk of neurodegenerative disease decades after exposure. A large retrospective cohort study of a population exposed to trichloroethylene in contaminated drinking water found an approximately seventy percent higher risk of Parkinson's disease relative to an unexposed comparison population. Trichloroethylene is a volatile organic solvent with widespread historical industrial, occupational, and environmental use, and its association with parkinsonism is supported both by this cohort evidence and by experimental models of mitochondrial and dopaminergic injury. CALIBRATION: this is a retrospective cohort association in a specifically exposed population, not a controlled trial. It establishes solvent exposure as a credible, latent contributor to neurodegenerative risk decades after exposure, and it supports the framework's emphasis on lifetime exposure history as a clinical variable.

Goldman SM, et al. (2023). Trichloroethylene exposure and Parkinson's disease risk in a contaminated water cohort. JAMA Neurology.

[STRONG] Per- and polyfluoroalkyl substances persist in the body and the environment, and authoritative regulatory bodies now recognize no established safe exposure threshold. PFAS are a class of thousands of synthetic compounds, often called forever chemicals, that resist environmental and metabolic breakdown and bioaccumulate across the lifespan. In 2024 the United States Environmental Protection Agency finalized the first enforceable national drinking water limits for several PFAS at four parts per trillion, while setting the non enforceable public health goal at zero, a formal regulatory acknowledgment that for these compounds no level of exposure is established as safe. PFAS exposure is associated in the peer reviewed literature with immune, lipid, thyroid, hepatic, and renal effects and with certain cancers. This is the clearest contemporary example of a persistent synthetic exposure whose body burden cannot be assumed to have a safe threshold, directly supporting the framework's emphasis on cumulative toxic burden reduction.

U.S. Environmental Protection Agency (2024). PFAS National Primary Drinking Water Regulation. First enforceable national limits, four parts per trillion PFOA and PFOS; maximum contaminant level goal set at zero.

[STRONG] Benzene is an established human carcinogen whose primary biological target is the hematopoietic system. The International Agency for Research on Cancer classifies benzene as a Group 1 agent, carcinogenic to humans. It is an established cause of acute myeloid leukemia and is associated with aplastic anemia and myelodysplastic syndromes. Benzene is a ubiquitous environmental and occupational exposure, present in fuels, combustion products, tobacco smoke, and many industrial processes. Its established carcinogenicity demonstrates a direct mechanistic link between a common environmental toxicant and dysfunction of the bone marrow, the body's hematopoietic and immune regenerative core, connecting the toxic burden territory to the immune and structural systems and illustrating the cascade architecture across systems.

International Agency for Research on Cancer. Benzene. IARC Monographs, Group 1 carcinogen. American Cancer Society. Benzene and cancer risk.

Clinical Significance for the NAP Framework

The detoxification system evidence establishes that toxic burden assessment is not optional in modern clinical practice. The general population carries measurable body burdens of multiple synthetic chemicals. These burdens are associated with chronic disease across every category of medical concern. The cumulative exposure reality means that single substance assessment is clinically inadequate. The NAP framework's First Domain emphasis on comprehensive toxin assessment and staged mobilization protocols reflects the documented biological reality that conventional medical practice does not adequately address.

TERRITORY THREE: NUTRIENT STATUS AND MICRONUTRIENT INSUFFICIENCY

Research Question

Are modern populations affected by widespread micronutrient depletion that drives chronic disease, and is this depletion addressable through systematic nutritional intervention?

Evidence Summary

[STRONG] Modern populations exhibit widespread suboptimal status of multiple essential nutrients, with measurable health consequences. National Health and Nutrition Examination Survey data, similar surveys in other developed nations, and population biomarker studies have documented that substantial portions of modern populations exhibit suboptimal status of magnesium, zinc, selenium, vitamin D, vitamin K2, B vitamin complex including B12 and folate, omega three fatty acids, and other essential nutrients. The depletion is driven by soil mineral depletion affecting nutritional density of food, modern dietary patterns emphasizing processed foods over nutrient dense whole foods, increased physiological demand from chronic stress and toxic burden, pharmaceutical effects depleting specific nutrients, malabsorption from gut dysfunction, and aging related decline in absorption efficiency.

Centers for Disease Control and Prevention. National Report on Biochemical Indicators of Diet and Nutrition. Periodic NHANES based reports.

DiNicolantonio JJ, et al. (2018). Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart.

Holick MF (2017). The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders.

[STRONG] Omega three fatty acid status is suboptimal in modern populations and is associated with increased risk of cardiovascular, neurological, and psychiatric disease. The modern Western dietary pattern produces an omega six to omega three ratio of approximately 15:1 to 17:1 against an evolutionary baseline of approximately 1:1, driven by industrial seed oil consumption and inadequate marine source fatty acid intake. This imbalance is associated with increased systemic inflammation, neurological dysfunction, cardiovascular disease, and psychiatric conditions including depression and increased suicide risk in vulnerable populations. The mechanism is established through omega three fatty acids' role in neuronal membrane integrity, neurotransmitter function, anti inflammatory eicosanoid synthesis, and broader physiological signaling. Targeted omega three repletion produces measurable clinical improvements across multiple condition categories in randomized controlled trials.

Simopoulos AP (2016). An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity and Other Chronic Diseases. Nutrients.

Lewis MD, et al. (2011). Suicide Deaths of Active-Duty US Military and Omega-3 Fatty-Acid Status. Journal of Clinical Psychiatry. PubMed PMID 21903029.

Mocking RJT, et al. (2016). Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Translational Psychiatry.

[STRONG] Magnesium depletion alone affects multiple biological systems through documented enzymatic mechanisms. Magnesium is required for over three hundred enzymatic reactions in human biology, including neurotransmitter synthesis and release, cortisol regulation, sleep architecture maintenance, muscle relaxation, cardiac rhythm regulation, insulin signaling, energy production, and detoxification pathway function. Modern populations exhibit widespread subclinical magnesium deficiency that is rarely identified through standard clinical testing because serum magnesium does not accurately reflect intracellular status. Subclinical magnesium deficiency contributes to cardiovascular disease, type 2 diabetes, anxiety and depression, sleep disorders, headache disorders, and metabolic syndrome. Targeted magnesium repletion produces measurable clinical improvements documented in peer reviewed clinical trials.

DiNicolantonio JJ, et al. (2018). Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. Foundational review.

Costello R, et al. (2016). Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium. Advances in Nutrition. Establishes the inadequacy of standard serum magnesium testing.

[STRONG] Vitamin D insufficiency affects substantial portions of the global population with consequences across immune, bone, cardiovascular, and broader health domains. Population biomarker studies have documented that substantial portions of populations across multiple geographic regions exhibit vitamin D insufficiency or deficiency, with prevalence varying by latitude, season, skin pigmentation, and lifestyle factors. Vitamin D affects gene expression at thousands of regulated targets, with consequences for immune function, bone health, cardiovascular health, neurological function, and broader physiological regulation. Insufficiency is associated with increased risk of multiple chronic disease categories, and targeted repletion produces measurable improvements in many of these outcomes.

Holick MF (2017). The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Reviews in Endocrine and Metabolic Disorders.

Pludowski P, et al. (2018). Vitamin D supplementation guidelines. Journal of Steroid Biochemistry and Molecular Biology.

[STRONG] Heavy metal burden interferes with the absorption and biological function of essential minerals, linking toxic burden directly to nutrient insufficiency. Lead, for example, shares absorption pathways and biochemical targets with calcium, iron, and zinc, competing with and displacing them, so that mineral repletion in an individual carrying a high metal burden can fail until the metal burden itself is addressed. This is a documented mechanism connecting the toxic burden and nutrient depletion territories.

Agency for Toxic Substances and Disease Registry. Toxicological Profile for Lead. (mineral interaction and substitution mechanisms).

[MODERATE] Essential omega 3 fatty acid status is associated with mood and neuropsychiatric outcomes, and omega 3 is a structural substrate of the brain rather than an optional supplement. Docosahexaenoic acid is the most abundant structural fatty acid in neuronal membranes; lower omega 3 status has been associated with depression, and in a case control study of active duty service members, with elevated suicide risk. CALIBRATION: these are associations, not proof of causation; interventional confirmation is the appropriate research priority, and a fixed population prevalence of deficiency should not be inferred from case control data.

Lewis MD, et al. (2011). Suicide deaths of active duty US military and omega 3 fatty acid status: a case control comparison. Journal of Clinical Psychiatry.

Clinical Significance for the NAP Framework

The nutrient status evidence establishes that nutrient depletion is a documented driver of chronic disease across populations and is addressable through systematic nutritional intervention. The NAP framework's emphasis on comprehensive nutrient assessment and targeted repletion as foundational clinical work reflects the actual biological reality of modern populations. Standard pharmaceutical management that does not address underlying nutrient depletion may produce symptomatic relief while leaving the foundational driver of dysfunction unaddressed.

TERRITORY FOUR: MICROBIOME, GUT BARRIER, AND THE GUT BRAIN AXIS

Research Question

Does the gut microbiome and gut barrier function affect health across multiple biological systems, and does dysfunction in this domain drive chronic disease in modern populations?

Evidence Summary

[STRONG] The gut microbiome is integrated with multiple body systems through documented signaling pathways and substantially affects host health. Peer reviewed research over the past two decades has established that the gut microbiome, comprising trillions of microbial cells across thousands of species, produces metabolites that affect host metabolism, signals to the immune system that affects immune function and tolerance, communicates with the central nervous system through multiple pathways collectively termed the gut brain axis, affects hormone metabolism through the estrobolome and related microbial subsystems, and influences inflammatory regulation throughout the body. Microbiome composition and function affect the risk and progression of cardiovascular disease, metabolic disease, autoimmune disease, neurological and psychiatric conditions, and broader health outcomes.

Cryan JF, et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews. Foundational review. Gilbert JA, et al. (2018). Current understanding of the human microbiome. Nature Medicine. Adak A, Khan MR (2019). An insight into gut microbiota and its functionalities. Cellular and Molecular Life Sciences.

[STRONG] Modern lifestyle and dietary patterns disrupt microbiome composition with measurable health consequences. Peer reviewed research has documented that modern Western dietary patterns, antibiotic exposure across the lifespan, glyphosate and other agricultural chemical residues, processed food consumption, chronic stress, and broader lifestyle factors disrupt the diversity and functional capacity of the gut microbiome. The disruption is associated with increased risk of inflammatory bowel disease, irritable bowel syndrome, obesity, type 2 diabetes, autoimmune conditions, mood disorders, and broader chronic disease. Microbiome restoration through dietary modification, targeted probiotic intervention, prebiotic fiber, fermented foods, and lifestyle change produces measurable improvements documented in clinical research.

Sonnenburg ED, Sonnenburg JL (2019). The ancestral and industrialized gut microbiota and implications for human health. Nature Reviews Microbiology.

Mesnage R, Antoniou MN (2020). Computational modelling provides insight into the effects of glyphosate on the shikimate pathway in the human gut microbiome. Current Research in Toxicology.

[STRONG] Intestinal permeability increase, often termed leaky gut, drives systemic inflammation through documented mechanisms. Peer reviewed research has established that increased intestinal permeability, measured through validated markers including zonulin and lactulose mannitol ratios, allows bacterial lipopolysaccharides and other inflammatory molecules to translocate from gut lumen into systemic circulation. This translocation triggers inflammatory cascades that drive autoimmune conditions, neuroinflammation, metabolic disease, and contributing pathology in multiple chronic disease categories. The clinical relevance of intestinal permeability has emerged from technical research curiosity to recognized contributor to chronic disease over the past two decades.

Fasano A (2020). All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research.

Camilleri M (2019). Leaky gut: mechanisms, measurement and clinical implications in humans. Gut.

[STRONG] Parasitic infection prevalence varies by geography but affects substantial portions of global populations with chronic health consequences. Parasitic infections including protozoal infections such as Giardia, Cryptosporidium, and Entamoeba, and helminthic infections including various worm species affect substantial portions of populations particularly in tropical and subtropical regions, in populations exposed to contaminated water and food, and in occupational and travel related contexts. Chronic parasitic colonization can persist asymptomatically while producing systemic effects including immune activation, nutrient malabsorption, gut barrier disruption, and contribution to broader chronic disease. The integration of parasitology assessment into comprehensive clinical practice is supported by World Health Organization recognition of parasitic disease as a major global health concern.

World Health Organization. Soil-transmitted helminth infections. Fact sheet and ongoing surveillance reports.

Aronson NE, et al. (2006). In harm's way: infections in deployed American military forces. Clinical Infectious Diseases.

[STRONG] Intestinal barrier integrity is a regulated physiological variable whose disruption permits immune activating molecules to enter systemic circulation. Increased intestinal permeability, mediated in part by zonulin signaling, is documented in association with autoimmune, inflammatory, and metabolic conditions, providing a mechanistic route by which gut dysfunction drives systemic inflammation and neuroinflammation. CALIBRATION: barrier dysfunction is established in specific conditions, but the popular term "leaky gut" is sometimes extended beyond what the evidence supports; the regulated, condition specific phenomenon is what the framework relies on.

Fasano A (2011). Zonulin and its regulation of intestinal barrier function. Physiological Reviews.

[MODERATE] The gut microbiome responds rapidly and reproducibly to diet, establishing nutrition as a direct and modifiable regulator of the microbial ecosystem and its downstream metabolic and neurological effects.

David LA, et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature.

Clinical Significance for the NAP Framework

The microbiome and gut barrier evidence establishes the foundational role of the second NAP biological system in chronic disease across populations. The integration of nutrient absorption, microbial balance, gut barrier function, and the gut brain axis represents one of the most significant areas of medical advancement in the past two decades. The NAP framework's emphasis on comprehensive gut assessment and integrated restoration reflects the actual biological reality that conventional pharmaceutical practice has historically underrecognized.

TERRITORY FIVE: MITOCHONDRIAL FUNCTION AND ENERGY METABOLISM

Research Question

Does mitochondrial function affect health across multiple biological systems, and does mitochondrial dysfunction drive chronic disease and aging in modern populations?

Evidence Summary

[STRONG] Mitochondrial dysfunction is a documented contributor to multiple chronic disease categories. Peer reviewed research has established mitochondrial dysfunction as a contributing factor in cardiovascular disease, neurodegenerative disease including Alzheimer's and Parkinson's diseases, type 2 diabetes and metabolic syndrome, chronic fatigue conditions, mood disorders, and the broader category of aging related decline. Mitochondrial damage from oxidative stress, environmental toxin exposure, pharmaceutical effects, nutrient cofactor deficiency, and chronic inflammation produces cellular energy deficit that affects function across all tissues that depend on adequate energy production.

Picard M, et al. (2018). Mitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stress. Proceedings of the National Academy of Sciences. Wallace DC (2018). Mitochondrial genetic medicine. Nature Genetics. Picard M, McEwen BS (2018). Psychological Stress and Mitochondria: A Conceptual Framework. Psychosomatic Medicine.

[STRONG] Metabolic flexibility and insulin sensitivity affect health across multiple disease categories beyond classical metabolic disease. Peer reviewed research has established that metabolic flexibility, the ability to switch between glucose and fatty acid oxidation as primary cellular fuel sources, declines in modern populations under the influence of chronic carbohydrate excess, sedentary lifestyle, and chronic stress. The decline produces insulin resistance, leptin resistance, and broader metabolic dysfunction that affects not only classical metabolic disease but also cardiovascular health, neurological function, hormonal regulation, immune function, and aging. Restoration of metabolic flexibility through dietary modification, exercise programming, and targeted nutritional intervention produces measurable improvements across multiple health domains.

Goodpaster BH, Sparks LM (2017). Metabolic Flexibility in Health and Disease. Cell Metabolism. Galgani JE, et al. (2008). Metabolic flexibility and insulin resistance. American Journal of Physiology - Endocrinology and Metabolism.

[MODERATE] Mitochondrial restoration through targeted nutrient and lifestyle intervention produces measurable clinical improvements. Peer reviewed research has documented that targeted nutritional intervention including coenzyme Q10, alpha lipoic acid, L carnitine, B vitamin complex, and emerging compounds such as nicotinamide adenine dinucleotide precursors produces measurable improvements in mitochondrial function in populations with documented dysfunction. Exercise programming, particularly high intensity interval training and resistance exercise, increases mitochondrial biogenesis and function. Caloric restriction and intermittent fasting protocols affect mitochondrial function and broader metabolic regulation. The clinical evidence base for these interventions varies from well established to emerging and continues to mature.

Hern\xE1ndez-Camacho JD, et al. (2018). Coenzyme Q10 Supplementation in Aging and Disease. Frontiers in Physiology. Verdin E (2015). NAD+ in aging, metabolism, and neurodegeneration. Science.

[MODERATE] Heavy metals and environmental toxicants impair mitochondrial function, linking toxic burden to cellular energy failure. Multiple metals disrupt the electron transport chain and elevate oxidative stress, contributing to the fatigue, exercise intolerance, and metabolic dysfunction associated with chronic exposure. This connects the toxic burden territory to the energy metabolism territory through documented mechanism. CALIBRATION: mechanism is well documented in experimental models and exposed populations; the magnitude of clinical contribution in any individual depends on cumulative burden and is established through assessment rather than assumption.

Metal toxicity in the central nervous system: mitochondrial and oxidative mechanisms. Environmental Health Perspectives. PMC1474439.

Clinical Significance for the NAP Framework

The mitochondrial and metabolic evidence establishes the third NAP biological system as foundational to health across multiple disease categories. The chronic fatigue, exercise intolerance, cognitive decline, and accelerated aging that affect substantial portions of modern populations frequently reflect underlying mitochondrial and metabolic dysfunction that responds to targeted intervention. The NAP framework's integration of mitochondrial restoration into comprehensive clinical practice reflects the documented importance of cellular energy production in determining health outcomes.

TERRITORY SIX: HORMONAL DYSREGULATION ACROSS THE LIFESPAN

Research Question

Does hormonal dysregulation affect modern populations across the lifespan, and is this dysregulation addressable through nutraceutical, botanical, lifestyle, and where indicated bioidentical hormonal intervention?

Evidence Summary

[STRONG] Endocrine disrupting chemical exposure is widespread in modern populations with documented hormonal consequences. The Endocrine Society has issued formal scientific statements documenting that environmental chemicals classified as endocrine disruptors, including bisphenols, phthalates, polybrominated diphenyl ethers, perfluorinated compounds, organochlorine pesticides, and others, affect hormonal signaling in human populations through multiple mechanisms including receptor binding, hormone synthesis disruption, hormone metabolism alteration, and feedback loop disruption. Population biomonitoring documents widespread exposure beginning prenatally and continuing across the lifespan. The hormonal consequences contribute to reproductive dysfunction, metabolic disease, hormone responsive cancers, and broader endocrine disease patterns.

Gore AC, et al. (2015). EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews. Diamanti-Kandarakis E, et al. (2009). Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocrine Reviews. Original 2009 statement.

[STRONG] Male testosterone levels have declined substantially across the population over recent decades. Peer reviewed research has documented substantial declines in male testosterone levels across the developed world over the past several decades, with the trend not fully explained by aging or measurement methodology. Causes implicated include endocrine disrupting chemical exposure, obesity epidemic effects on hormonal regulation, sleep deprivation, chronic stress, sedentary lifestyle, and dietary pattern changes. The decline is associated with increased rates of fatigue, depression, sexual dysfunction, muscle loss, cognitive decline, and contributing pathology in cardiovascular and metabolic disease. Targeted natural intervention including specific botanical and nutritional approaches, exercise programming, sleep restoration, and stress management produces measurable testosterone improvement in many cases.

Travison TG, et al. (2007). A population-level decline in serum testosterone levels in American men. Journal of Clinical Endocrinology and Metabolism. Foundational documentation.

Lokeshwar SD, et al. (2021). Decline in serum testosterone levels among adolescent and young adult men in the USA. European Urology Focus.

[STRONG] Female hormonal transitions across the lifespan are inadequately addressed by conventional medical practice. Peer reviewed research has documented that female hormonal transitions including menarche, reproductive years, perimenopause, and menopause produce health consequences that conventional medical practice frequently mismanages or undertreats. The Women's Health Initiative findings on synthetic hormone replacement therapy created widespread reluctance to prescribe even appropriate hormonal support, leaving substantial portions of the female population without adequate clinical attention to documented hormonal dysfunction. Targeted natural intervention through botanical, nutritional, lifestyle, and where indicated bioidentical hormonal support addresses the gap in conventional care for many patients.

Manson JE, et al. (2017). Menopause Management - Getting Clinical Care Back on Track. New England Journal of Medicine.

Stuenkel CA, et al. (2015). Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism.

[STRONG] Adrenal and HPA axis dysregulation from chronic stress affects health across multiple systems. Peer reviewed research has established that chronic stress produces sustained activation of the hypothalamic pituitary adrenal axis with downstream effects on cortisol regulation, sex hormone production, thyroid function, immune regulation, and metabolic function. The clinical manifestations include chronic fatigue, sleep disturbance, mood disorders, weight regulation difficulty, immune dysregulation, and contributing pathology in metabolic and cardiovascular disease. Targeted intervention through adaptogenic botanical support, nutritional cofactor optimization, stress management practices, and lifestyle modification produces measurable improvements in HPA axis function in many populations.

McEwen BS (2017). Neurobiological and Systemic Effects of Chronic Stress. Chronic Stress.

Sapolsky RM, et al. (2000). How do glucocorticoids influence stress responses? Endocrine Reviews. Foundational review.

[STRONG] Thyroid dysfunction is widespread and frequently undertreated in modern populations. Peer reviewed research has documented that thyroid dysfunction including subclinical hypothyroidism, autoimmune thyroid disease, and broader thyroid regulatory dysfunction affects substantial portions of modern populations. The conventional reliance on TSH testing alone misses substantial portions of the dysfunctional population. Comprehensive thyroid assessment including free T3, free T4, reverse T3, and thyroid antibodies provides more complete clinical picture. Underlying drivers including iodine status, selenium deficiency, autoimmune activation from gut barrier dysfunction, and environmental endocrine disruptor exposure are frequently addressable through integrated intervention.

Garber JR, et al. (2012). Clinical practice guidelines for hypothyroidism in adults. Endocrine Practice. Wartofsky L, Dickey RA (2005). The evidence for a narrower thyrotropin reference range is compelling. Journal of Clinical Endocrinology and Metabolism.

[STRONG] Sleep restriction directly lowers testosterone, demonstrating that hormonal status is downstream of modifiable terrain and lifestyle factors rather than fixed. In a controlled study, one week of sleep restriction to approximately five hours per night reduced daytime testosterone by roughly ten to fifteen percent in healthy young men. This establishes sleep restoration as a legitimate, evidence based hormonal intervention and illustrates the cascade link between the neurological, sleep, and endocrine systems.

Leproult R, Van Cauter E (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA.

[MODERATE] Endocrine disrupting chemicals interfere with hormonal signaling at environmentally relevant doses, connecting the hormonal regulation territory to the toxic burden territory through documented mechanism.

Gore AC, et al. (2015). EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews.

Clinical Significance for the NAP Framework

The hormonal evidence establishes the fourth NAP biological system as a foundational driver of chronic disease and quality of life concerns across populations and across the lifespan. From declining male testosterone to undertreated female hormonal transitions to widespread thyroid dysfunction to chronic stress effects on HPA axis function, modern populations face hormonal challenges that conventional pharmaceutical management frequently does not adequately address. The NAP framework's integration of natural hormonal restoration as a primary clinical approach, with bioidentical hormonal therapy as a secondary intervention when natural approaches prove insufficient, addresses the documented clinical reality.

TERRITORY SEVEN: NEUROLOGICAL FUNCTION AND COGNITIVE HEALTH

Research Question

Does neurological dysfunction in modern populations have identifiable biological drivers that respond to terrain restoration, and is the dominant pharmaceutical model adequately addressing the chronic neurological and psychiatric conditions affecting modern populations?

Evidence Summary

[STRONG] Neuroinflammation is a documented contributor to multiple neurological and psychiatric conditions. Peer reviewed research has established neuroinflammation as a contributor to depression, anxiety disorders, cognitive decline, neurodegenerative disease, and broader neurological dysfunction. The mechanisms include systemic inflammation crossing the blood brain barrier, gut barrier dysfunction allowing inflammatory molecule translocation that affects neural tissue, microglial activation, and the broader integration of immune and neurological systems. Targeted anti inflammatory intervention through nutritional, botanical, and lifestyle approaches produces measurable improvements in many neuroinflammatory conditions.

Heneka MT, et al. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology. Miller AH, Raison CL (2016). The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology.

[STRONG] Essential fatty acid status, particularly omega three and DHA, affects neurological function and psychiatric outcomes. Peer reviewed research has established that docosahexaenoic acid constitutes a substantial portion of neuronal membrane structure and is essential for neuronal function. Population studies document widespread omega three insufficiency. Specific clinical research has documented associations between low DHA status and increased risk of depression, suicide, cognitive decline, and broader neuropsychiatric concerns. Targeted omega three repletion produces measurable improvements in many neuropsychiatric conditions in randomized controlled trials.

Lewis MD, et al. (2011). Suicide Deaths and Omega-3 Fatty-Acid Status. Journal of Clinical Psychiatry. PubMed PMID 21903029. Mocking RJT, et al. (2016). Meta-analysis of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Translational Psychiatry.

[STRONG] Heavy metal accumulation in neural tissue produces documented neurotoxic effects.

Peer reviewed toxicology research has established that heavy metals including lead, mercury, aluminum, cadmium, and others accumulate in neural tissue, particularly in the prefrontal cortex and other regions critical for executive function and emotional regulation, and produce neurotoxic effects through multiple mechanisms. The mechanisms include direct neuronal damage, oxidative stress, dendritic spine disruption, neurotransmitter system interference, and mitochondrial dysfunction in neurons. The clinical manifestations include cognitive decline, mood disorders, executive function impairment, and impulsive behavior including suicidal behavior in vulnerable populations.

Co-exposure to lead, mercury, and cadmium induces neurobehavioral impairments via dopaminergic and serotonergic neurotransmission disruption (2023). Frontiers in Public Health. PMC10662100.

Co-exposure to low-dose lead, cadmium, and mercury promotes memory deficits via dendritic spine pruning (2023). ScienceDirect.

[MODERATE] Conventional psychiatric pharmaceutical practice produces limited improvement in chronic mental health outcomes despite expanded prescribing. Population health data has documented that despite substantial expansion of psychiatric pharmaceutical prescribing over recent decades, mental health outcomes including depression rates, suicide rates, and broader measures of psychiatric distress have not improved at population level and have worsened in many demographic categories. The pharmaceutical only model of psychiatric care has been criticized in peer reviewed literature for inadequately addressing underlying biological drivers of psychiatric symptoms including nutritional deficiency, neuroinflammation, hormonal dysregulation, gut microbiome dysfunction, and environmental toxin exposure. Integrative psychiatry as a developing clinical subspecialty addresses the limitations of pharmaceutical only management.

Mojtabai R, et al. (2014). National trends in long-term use of antidepressant medications. Journal of Clinical Psychiatry.

Lake J (2015). The integrative management of PTSD: A review of conventional and CAM approaches. Mental Health Clinician.

[STRONG] Psychiatric polypharmacy is associated with elevated mortality risk independent of underlying diagnoses. Peer reviewed research has established that long term psychoactive medication use and psychoactive polypharmacy independently predict increased risk of suicide and unintentional overdose death, even after controlling for the psychiatric diagnoses for which the medications were prescribed. The finding indicates that the medications themselves, or the patterns of their use, contribute to mortality risk separately from the conditions they are intended to treat. The clinical implication is that pharmaceutical management requires careful consideration of the medication burden itself as a clinical factor, and that integrated approaches addressing underlying biology may produce better outcomes than continued pharmaceutical escalation.

Long-term Psychoactive Medications, Polypharmacy, and Risk of Suicide and Unintended Overdose Death (2022). Journal of General Internal Medicine. PubMed PMID 36042093. Morin R, et al. (2020). High-Risk Medication Use and Polypharmacy in Older Adults. Innovation in Aging.

[MODERATE] Contrary to a widespread popular claim, statin therapy is not associated with increased dementia risk; current large reviews find a neutral to protective relationship. A 2025 systematic review and meta analysis encompassing 55 studies and more than seven million participants found a pooled hazard ratio of approximately 0.86, indicating lower dementia risk among statin users, consistent with earlier meta analyses. CALIBRATION: this corrects an over claim that circulates in integrative and popular media. The brain's dependence on cholesterol is real, but it does not support the claim that statins cause dementia. The framework's credibility depends on following the evidence even where it contradicts a popular narrative.

Westphal Filho FL, et al. (2025). Statin use and dementia risk: a systematic review and meta analysis. Alzheimer's & Dementia: Translational Research & Clinical Interventions.

[MODERATE] The adult brain retains the capacity for structural and functional change in response to targeted intervention, providing the biological basis for neurological restoration rather than mere symptom management.

Adult neuroplasticity literature (structural change and fear extinction learning). (Representative reviews; format at publication.)

Clinical Significance for the NAP Framework

The neurological evidence establishes that the fifth NAP biological system represents a critical area where current pharmaceutical practice is producing inadequate population health outcomes. The integrated drivers of neurological dysfunction including neuroinflammation, essential fatty acid deficiency, heavy metal accumulation, microbial imbalance, and hormonal dysregulation are documented in peer reviewed literature and respond to terrain restoration approaches. The NAP framework's integration of comprehensive neurological assessment and multi-domain restoration addresses the documented gap in current standard of care.

TERRITORY EIGHT: IMMUNE FUNCTION AND INFLAMMATORY REGULATION

Research Question

Are immune dysregulation and chronic inflammation foundational drivers of chronic disease in modern populations, and do these conditions respond to integrated intervention addressing underlying drivers?

Evidence Summary

[STRONG] Chronic low grade inflammation is a documented driver of multiple chronic disease categories. Peer reviewed research has established chronic low grade inflammation, often termed inflammaging or metaflammation, as a driver of cardiovascular disease, type 2 diabetes, neurodegenerative disease, autoimmune conditions, multiple cancers, and accelerated aging. The drivers of chronic inflammation include omega six to omega three fatty acid imbalance from modern dietary patterns, gut barrier dysfunction with bacterial product translocation, chronic infection, environmental toxin exposure, chronic stress effects on immune function, sleep deprivation, and obesity related inflammatory signaling. Addressing the underlying drivers through integrated intervention produces measurable inflammatory marker improvement and clinical benefit across multiple conditions.

Hotamisligil GS (2017). Inflammation, metaflammation and immunometabolic disorders. Nature. Franceschi C, et al. (2018). Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology.

[STRONG] Autoimmune disease prevalence has increased substantially in developed populations. Peer reviewed epidemiological research has documented substantial increases in autoimmune disease prevalence across developed populations over recent decades. The increase affects multiple specific autoimmune conditions and broader autoimmune patterns. Causes implicated include the hygiene hypothesis effects on immune training, microbiome disruption from antibiotic exposure and dietary patterns, environmental toxin exposure with immunological effects, gut barrier dysfunction, vitamin D deficiency, and broader environmental factors. The pharmaceutical management approach typically focuses on immunosuppression rather than addressing underlying drivers, producing symptomatic management without resolution of the underlying immune dysregulation.

Lerner A, et al. (2015). The World Incidence and Prevalence of Autoimmune Diseases is Increasing. International Journal of Celiac Disease. Bach JF (2002). The effect of infections on susceptibility to autoimmune and allergic diseases. New England Journal of Medicine. Foundational hygiene hypothesis review.

[STRONG] Vitamin D, omega three fatty acids, and broader nutritional factors substantially affect immune function. Peer reviewed research has established that vitamin D status, omega three fatty acid status, zinc status, selenium status, and broader nutritional factors substantially affect immune competence and inflammatory regulation. Population insufficiency of these nutrients contributes to suboptimal immune function and increased susceptibility to infection and inflammatory disease. Targeted repletion produces measurable immune function improvements in deficient populations. The clinical implication is that nutritional assessment and intervention is foundational to immune health rather than peripheral.

Calder PC (2020). Nutrition, immunity and COVID-19. BMJ Nutrition, Prevention and Health. Aranow C (2011). Vitamin D and the Immune System. Journal of Investigative Medicine.

[STRONG] Gut microbiome composition fundamentally shapes immune function across the lifespan. Peer reviewed research has established that the gut microbiome is the largest immune organ in the body and that microbiome composition and function fundamentally shape immune development, immune training, immune tolerance, and ongoing immune regulation. Microbiome disruption through antibiotic exposure, dietary patterns, and environmental factors produces immune dysregulation contributing to allergic disease, autoimmune conditions, infection susceptibility, and broader immune dysfunction. Microbiome restoration is foundational to immune health restoration.

Belkaid Y, Hand TW (2014). Role of the microbiota in immunity and inflammation. Cell. Round JL, Mazmanian SK (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nature Reviews Immunology.

[STRONG] Chronic inflammation is not merely a marker of chronic disease but a causal driver, as demonstrated by interventional trial evidence. In a large randomized controlled trial, targeting inflammation directly with an anti inflammatory agent, independent of any lipid lowering effect, reduced recurrent cardiovascular events, establishing that inflammation is causal in atherosclerotic disease rather than an incidental correlate. This is foundational support for the framework's treatment of the inflammatory cascade as a primary intervention target.

Ridker PM, et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS). New England Journal of Medicine.

[MODERATE] Low grade chronic inflammation increases with age, a phenomenon termed inflammaging, and represents a shared mechanism across multiple chronic disease categories, consistent with the framework's treatment of the inflammatory cascade as a cross system driver.

Franceschi C, et al. Inflammaging: chronic low grade inflammation in aging. (Representative reviews; format at publication.)

Clinical Significance for the NAP Framework

The immune and inflammatory evidence establishes the sixth NAP biological system as foundational to chronic disease across nearly every category. The integrated drivers of immune dysregulation including microbial imbalance, nutritional deficiency, environmental toxin exposure, chronic stress, and broader lifestyle factors are documented in peer reviewed literature and respond to integrated intervention. The NAP framework's emphasis on addressing underlying immune drivers rather than only managing immune symptoms reflects the documented biological reality.

TERRITORY NINE: CARDIOVASCULAR AND METABOLIC HEALTH

Research Question

Are cardiovascular and metabolic disease in modern populations driven by addressable terrain factors, and does integrated intervention produce better outcomes than single agent pharmaceutical management?

Evidence Summary

[STRONG] Cardiovascular disease etiology integrates inflammatory, metabolic, oxidative, and microbial factors beyond lipid metrics alone. Peer reviewed research has substantially expanded the understanding of cardiovascular disease etiology beyond the traditional cholesterol focused model. Inflammation, oxidative stress, insulin resistance, microbiome composition, endothelial dysfunction, advanced glycation end products, and homocysteine elevation contribute to cardiovascular risk independent of and in interaction with traditional lipid measures. Advanced lipid testing including particle size analysis provides more clinically relevant risk assessment than total cholesterol alone. The integrated etiology supports comprehensive cardiovascular intervention addressing multiple drivers rather than single agent statin focused management for many patients.

Ridker PM, et al. (2017). Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine. CANTOS trial.

Cromwell WC, et al. (2007). LDL Particle Number and Risk of Future Cardiovascular Disease. Journal of Clinical Lipidology.

[STRONG] Metabolic syndrome and insulin resistance affect substantial portions of modern populations with consequences across multiple disease categories. Peer reviewed epidemiological research has documented that metabolic syndrome, characterized by central obesity, insulin resistance, dyslipidemia, hypertension, and inflammatory markers, affects substantial portions of populations in developed nations. The condition is a major driver of cardiovascular disease, type 2 diabetes, neurodegenerative disease, certain cancers, and broader chronic disease. Drivers include dietary patterns emphasizing refined carbohydrates and industrial seed oils, sedentary lifestyle, chronic stress, sleep deprivation, environmental toxin exposure, and broader lifestyle factors. Integrated intervention through dietary pattern modification, structured exercise, stress management, sleep restoration, and targeted nutritional support produces measurable improvements documented in clinical research.

Saklayen MG (2018). The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports.

Esposito K, et al. (2010). Mediterranean diet and metabolic syndrome: an updated, systematic review. Reviews in Endocrine and Metabolic Disorders.

[STRONG] Targeted nutritional and botanical interventions produce measurable cardiovascular benefits in clinical research. Peer reviewed clinical research has documented cardiovascular benefits from targeted intervention with omega three fatty acids, magnesium, coenzyme Q10, vitamin K2, hawthorn, hibiscus, beet root nitrates, and broader cardiovascular tropic compounds. The benefits include blood pressure improvement, lipid panel improvement, endothelial function improvement, and in some populations cardiovascular event reduction. The integration of these interventions into comprehensive cardiovascular care, rather than as alternatives to appropriate conventional treatment, reflects the documented evidence base.

Bhatt DL, et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl. New England Journal of Medicine. REDUCE-IT trial. Hruby A, et al. (2014). Magnesium intake, quality of carbohydrates, and risk of type 2 diabetes. Diabetes Care.

[STRONG] Atherosclerosis is fundamentally an inflammatory disease of the arterial wall, not simply a disorder of cholesterol deposition. Decades of research establish that the atherosclerotic process is driven by inflammation interacting with lipid particles, reframing cardiovascular disease as a terrain and inflammation problem rather than a single number cholesterol problem, and supporting integrated cardiovascular restoration over isolated lipid targeting.

Libby P (2021). Inflammation in atherosclerosis: from pathophysiology to practice. (and Libby P, 2002, Nature).

[MODERATE] Insulin resistance and impaired metabolic flexibility are upstream drivers of cardiovascular and broader chronic disease, supporting metabolic restoration as a foundational rather than secondary intervention.

DiNicolantonio JJ, et al. (2018). Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. (metabolic and cardiovascular mineral cofactor pathway).

Clinical Significance for the NAP Framework

The cardiovascular and metabolic evidence establishes the seventh NAP biological system as a major area where integrated intervention addresses documented drivers of chronic disease that pharmaceutical only management does not adequately address. The expansion beyond cholesterol focused management to include inflammatory, metabolic, oxidative, and microbial factors reflects the actual biology of cardiovascular disease and supports the comprehensive NAP approach.

TERRITORY TEN: STRUCTURAL AND MUSCULOSKELETAL HEALTH

Research Question

Does structural and musculoskeletal health respond to terrain restoration approaches, and are modern populations affected by drivers of structural decline that integrated intervention can address?

Evidence Summary

[STRONG] Bone density and connective tissue health depend on integrated nutritional, hormonal, and mechanical factors. Peer reviewed research has established that bone density and broader connective tissue health depend on integrated factors including calcium, vitamin D, vitamin K2, magnesium, boron, and broader nutritional cofactors, hormonal status particularly affecting both sexes across the lifespan, mechanical loading through resistance exercise and weight bearing activity, and inflammatory regulation. The conventional approach focused on calcium and vitamin D alone, particularly in postmenopausal women, has been recognized as inadequate. Comprehensive intervention addressing the full nutritional and lifestyle context produces better bone health outcomes than single intervention approaches.

Weaver CM, et al. (2016). Calcium plus vitamin D supplementation and risk of fractures. Osteoporosis International. Akkawi I, Zmerly H (2018). Osteoporosis: Current Concepts. Joints.

[STRONG] Sarcopenia and muscle loss affect substantial portions of aging populations with health consequences beyond mobility. Peer reviewed research has documented that sarcopenia, the progressive loss of muscle mass and function with aging, affects substantial portions of populations over age sixty and produces consequences including increased mortality, increased falls and fractures, metabolic dysfunction, immune impairment, and reduced quality of life. Drivers include inadequate protein intake, vitamin D and broader nutritional insufficiency, hormonal changes, sedentary lifestyle, and inflammatory factors. Targeted intervention through resistance exercise, adequate protein intake, vitamin D and broader nutritional optimization, and where indicated hormonal support produces measurable improvements documented in clinical research.

Cruz-Jentoft AJ, et al. (2019). Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. Phillips SM, et al. (2016). Protein 'requirements' beyond the RDA: implications for optimizing health. Applied Physiology, Nutrition, and Metabolism.

[STRONG] Chronic pain syndromes have multifactorial drivers addressable through integrated intervention. Peer reviewed research has established that chronic pain syndromes have multiple contributing factors including inflammation, neuropathic mechanisms, structural and biomechanical factors, central sensitization, and psychosocial factors. The conventional pharmaceutical management focused on opioid and broader pain medication has produced documented harm including the opioid crisis affecting multiple developed nations. Integrated approaches addressing inflammation through nutritional and botanical intervention, addressing neuropathic mechanisms through specific nutrient and botanical support, addressing structural factors through movement therapy and manual intervention, and addressing central sensitization through somatic and contemplative practices produce improvements that can reduce or replace pharmaceutical pain management for many patients.

Tick H, et al. (2018). Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care. Explore. Hilton L, et al. (2017). Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Annals of Behavioral Medicine.

[STRONG] The skeleton is a long term storage reservoir for lead and other heavy metals, which are released back into circulation during states of high bone turnover, directly linking the structural system to toxic burden across the lifespan. Lead stored in bone over years to decades can be mobilized during pregnancy, lactation, menopause, prolonged immobilization, and aging, producing delayed internal re exposure from the body's own tissue, and demonstrating that the structural and detoxification systems are mechanistically coupled.

Agency for Toxic Substances and Disease Registry. Toxicological Profile for Lead. (bone storage half life and turnover related mobilization).

[MODERATE] Skeletal muscle functions as an endocrine organ, secreting signaling molecules that influence metabolic, immune, and neurological function, so that muscle maintenance is a systemic intervention rather than a purely structural one.

Myokine and muscle as secretory organ literature (Pedersen & Febbraio and related reviews; format at publication).

Clinical Significance for the NAP Framework

The structural and musculoskeletal evidence establishes the eighth NAP biological system as foundational to function and quality of life across the lifespan. The integration of nutritional, hormonal, mechanical, and inflammatory factors in structural health supports the comprehensive NAP approach that addresses these factors together rather than separately.

TERRITORY ELEVEN: THE DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE

Research Question

Does adult chronic disease originate in prenatal, perinatal, and early childhood developmental conditions, and does this lifespan trajectory perspective support preventive intervention across the lifespan?

Evidence Summary

[STRONG] Adult chronic disease frequently originates in prenatal and early life developmental conditions. The Developmental Origins of Health and Disease (DOHaD) framework, originating with David Barker's epidemiological research in the 1980s and developed through subsequent decades of peer reviewed research, has established that prenatal nutrition, intrauterine growth conditions, perinatal exposures, and early life developmental environment substantially affect adult risk of cardiovascular disease, type 2 diabetes, hypertension, neuropsychiatric conditions, respiratory disease, immune disorders, and broader chronic disease. The Dutch Hunger Winter cohort and similar natural experiments have documented epigenetic mechanisms through which prenatal environment produces lifelong health consequences. The International Society for Developmental Origins of Health and Disease coordinates the substantial international research effort in this domain.

Nobile S, et al. (2022). Perinatal Origins of Adult Disease and Opportunities for Health Promotion. Journal of Personalized Medicine. PMC8877993.

Bezek S, et al. (2010). Developmental origin of chronic diseases: toxicological implication. PMC2993479.

Heindel JJ, Vandenberg LN (2015). Developmental origins of health and disease: a paradigm for understanding disease cause and prevention. Current Opinion in Pediatrics.

[STRONG] Prenatal and early life environmental chemical exposure affects lifelong health risk. Peer reviewed research has documented that prenatal exposure to environmental chemicals including endocrine disruptors, heavy metals, persistent organic pollutants, and air pollution affects fetal development with consequences for neurodevelopment, metabolic programming, immune development, hormonal programming, and broader physiological function across the lifespan. Cord blood biomonitoring documents that newborns are exposed to hundreds of synthetic chemicals before birth. The mechanisms include direct toxicity, epigenetic programming, hormonal disruption during critical developmental windows, and broader developmental effects. The clinical implication is that prevention of chronic disease begins prenatally and that environmental medicine considerations apply across the lifespan from conception forward.

Pinson MR, et al. (2021). Extracellular Vesicles in Premature Aging and Diseases in Adulthood Due to Developmental Exposures. PMC8407878.

Heindel JJ, et al. (2015). Developmental Origins of Health and Disease: Integrating Environmental Influences. Endocrinology.

[STRONG] Maternal microbiome and breast feeding fundamentally shape infant immune and metabolic development. Peer reviewed research has established that maternal microbiome composition, mode of delivery affecting initial infant microbiome colonization, breast feeding versus formula feeding, and early childhood antibiotic exposure substantially affect infant microbiome development with consequences for immune system development, metabolic programming, neurological development, and lifelong chronic disease risk. Cesarean section delivery is associated with altered infant microbiome with consequences for asthma, allergic disease, and metabolic disease risk. Breast feeding produces benefits for immune development, metabolic programming, and broader health outcomes that extend into adulthood. Early antibiotic exposure produces microbiome disruption with consequences for asthma, allergic disease, obesity, and broader chronic disease risk.

Rasmussen MA, et al. (2020). Mode of delivery and microbiome composition. Nature Communications.

Victora CG, et al. (2016). Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet.

[STRONG] Adverse childhood experiences produce lifelong health consequences through multiple biological mechanisms. Peer reviewed research, originating with the Kaiser Permanente Adverse Childhood Experiences study and developed through subsequent decades of research, has documented that childhood trauma and adversity produce lifelong consequences for cardiovascular disease, autoimmune disease, mental health conditions, addiction, and broader chronic disease risk. The mechanisms include HPA axis dysregulation, telomere shortening, epigenetic effects on stress response systems, and broader biological embedding of early adversity. The clinical implication is that comprehensive health assessment includes early life history and that psychological and somatic intervention addressing early life trauma is foundational rather than peripheral to physical health.

Felitti VJ, et al. (1998). Relationship of Childhood Abuse and Household Dysfunction to Many of the Leading Causes of Death in Adults. American Journal of Preventive Medicine.

Shonkoff JP, et al. (2012). The lifelong effects of early childhood adversity and toxic stress. Pediatrics.

[MODERATE] Prenatal exposure to environmental chemicals is documented and is associated with offspring health outcomes, reinforcing the developmental origins framework. Biomonitoring detects numerous synthetic chemicals in maternal and cord blood, and prenatal exposures are associated with neurodevelopmental, metabolic, and endocrine outcomes in offspring, consistent with the principle that adult disease risk is shaped by exposures during sensitive developmental windows. CALIBRATION: associations between specific prenatal exposures and specific outcomes vary in strength; the established general principle is that the developmental window is uniquely sensitive to exposure.

Woodruff TJ, et al. (2011). Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environmental Health Perspectives.

Clinical Significance for the NAP Framework

The DOHaD evidence establishes that NAP is fundamentally a preventive medicine framework as well as a therapeutic one, and that the prevention applies across the lifespan beginning prenatally. The framework supports comprehensive prenatal and early life environmental, nutritional, and developmental optimization as foundational for lifelong health. It also supports recognition that adult patients carry lifelong consequences of their developmental origins, which inform individualized clinical approach.

TERRITORY TWELVE: THE CONVERGENCE OF MEDICAL DISCIPLINES

Research Question

Are multiple independent medical and scientific disciplines converging toward an integrated systems based clinical paradigm that aligns with the NAP framework?

Evidence Summary

[STRONG] Functional medicine has developed substantial peer reviewed presence and clinical infrastructure over recent decades. Functional medicine, organized through the Institute for Functional Medicine and parallel professional organizations, has developed peer reviewed publications, clinical training programs, certification standards, and growing institutional acceptance over recent decades. The American College of Physicians, Cleveland Clinic, and other mainstream medical institutions have established functional medicine programs. Peer reviewed publications including the integrative medicine journals have established the evidence base for functional medicine clinical practice. The functional medicine framework closely parallels the NAP framework in its emphasis on root cause investigation, systems based assessment, and integrated intervention.

Hyman M (2018). Functional medicine: an operating system for integrative health. JAMA editorial. Beidelschies M, et al. (2019). Association of the Functional Medicine Model of Care With Patient-Reported Health-Related Quality-of-Life Outcomes. JAMA Network Open.

[MODERATE] Integrative psychiatry has emerged as a distinct clinical subspecialty addressing the limitations of conventional psychiatric pharmaceutical management. Peer reviewed integrative psychiatry literature has developed substantially over recent decades, addressing the limitations of pharmaceutical only psychiatric care through integration of nutritional psychiatry, environmental psychiatry, lifestyle medicine for mental health, and broader integrative approaches. The American Psychiatric Association and parallel international bodies have begun acknowledging integrative approaches in mainstream practice guidelines. Specific evidence based interventions including nutritional intervention for depression, lifestyle intervention for psychiatric conditions, and emerging psychedelic therapies have entered mainstream conversation.

Sarris J, et al. (2015). Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry. Lake J (2015). The integrative management of PTSD: A review of conventional and CAM approaches. Mental Health Clinician.

[STRONG] Environmental medicine and clinical toxicology have developed substantial peer reviewed presence in mainstream medical literature. Environmental medicine and clinical toxicology, addressing the relationship between environmental exposures and human health, have developed substantial peer reviewed presence in mainstream medical literature including the Lancet Commission on pollution and health and the Endocrine Society scientific statements on endocrine disrupting chemicals. The disciplines have established that environmental exposure assessment and intervention is foundational to comprehensive medical practice rather than peripheral. The convergence of environmental medicine with broader integrative practice supports the NAP framework's integration of environmental medicine into comprehensive clinical practice.

Landrigan PJ, et al. (2018). The Lancet Commission on pollution and health. Lancet. Gore AC, et al. (2015). EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews.

[STRONG] Lifestyle medicine has developed substantial mainstream medical acceptance. Lifestyle medicine, organized through the American College of Lifestyle Medicine and parallel international bodies, has developed peer reviewed presence, certification programs, and growing mainstream medical institutional support over recent decades. Major medical institutions have established lifestyle medicine programs. The 2018 American Heart Association recognition of lifestyle medicine and the broader inclusion of lifestyle factors in major chronic disease prevention guidelines reflect the mainstream convergence toward lifestyle and integrated approaches that align with the NAP framework.

Lianov L, Johnson M (2010). Physician competencies for prescribing lifestyle medicine. JAMA. American College of Lifestyle Medicine. Annual reports and clinical practice resources.

[STRONG] Systems biology and network medicine have established the scientific foundation for integrated systems clinical practice. Systems biology and network medicine, developed primarily as research disciplines but with growing clinical translation, have established the scientific foundation for understanding human biology as integrated systems rather than as separate organ pathology. The clinical translation of systems biology supports the NAP framework's integrated systems approach with rigorous scientific grounding. The convergence of systems biology with clinical practice through emerging precision medicine and personalized medicine approaches further supports the integrated framework.

Barab\xE1si AL, et al. (2011). Network medicine: a network-based approach to human disease. Nature Reviews Genetics. Hood L, et al. (2015). Systems biology and P4 medicine. Rambam Maimonides Medical Journal.

[MODERATE] Whole person, integrative care models are being adopted at scale within major health systems, evidencing institutional convergence toward the paradigm the framework describes. The largest integrated health system in the United States has implemented a system wide Whole Health model that reorients care around the patient's goals and incorporates complementary and integrative health approaches alongside conventional care, demonstrating that the convergence described in this territory is operational, not merely theoretical.

U.S. Department of Veterans Affairs. Whole Health system and complementary and integrative health modalities.

[MODERATE] A functional medicine model of care has been associated with improved patient reported quality of life outcomes relative to conventional primary care, providing early systems level evidence for the integrated approach.

Beidelschies M, et al. (2019). Association of the Functional Medicine Model of Care with Patient-Reported Health-Related Quality-of-Life Outcomes. JAMA Network Open.

Clinical Significance for the NAP Framework

The convergence evidence establishes that NAP is not a fringe alternative paradigm but represents the unifying framework toward which multiple independent mainstream and emerging medical disciplines have been moving. Functional medicine, integrative psychiatry, environmental medicine, lifestyle medicine, systems biology, and broader integrative health movements share substantial overlap with the NAP framework while operating in fragmentary fashion without unified credentialing, standards, and infrastructure. NAP provides the unifying architecture that allows these convergent movements to function as a coherent global category rather than as fragmented practices.

DIAGNOSTIC VALIDITY AND THE NAP TESTING STANDARD

The credibility of the NAP framework depends not only on the evidence for its interventions but on the validity of the tests used to assess the terrain. A framework that intervenes on the basis of an invalid test is no more rigorous than one that prescribes without evidence. NAP therefore applies the same discipline to its diagnostics that it applies to its treatments: tests are classified by the strength of their analytical and clinical validity, the framework leads with validated assays, and it is explicit about which tests are supportive, which are emerging, and which are contested.

The Diagnostic Validity Tiers

[VALIDATED] Tests with established analytical and clinical validity, standardized reference ranges, and acceptance in conventional laboratory medicine. These are the backbone of NAP assessment. They include serum and red blood cell mineral and nutrient panels, the omega-3 index, high sensitivity C-reactive protein and standard inflammatory markers, comprehensive metabolic, hepatic, renal, and lipid panels, hemoglobin A1c, validated hormonal panels, validated stool pathogen and parasitology testing, blood lead and standard heavy-metal blood assays, and validated psychometric instruments.

[EMERGING] Tests that are increasingly used and mechanistically reasonable but whose reference standards or linkage to outcomes are still maturing. They may support clinical reasoning when interpreted with appropriate caution. They include advanced lipid particle analysis, organic acid testing for metabolic and mitochondrial markers, microbiome sequencing, and intestinal-permeability markers.

[CONTESTED] Adjunctive tests used in some integrative practice but lacking validated reference standards, or actively contested in the conventional literature. These may inform clinical reasoning but must never serve as the sole basis for a diagnosis or an intervention, and patients must be informed of their contested status. The clearest examples are hair tissue mineral analysis and provoked, or "challenge," urine metal testing — for which no validated reference ranges for provoked values exist and which are explicitly criticized by conventional toxicology.

The NAP Testing Standard

1. Lead with validated tests. Every NAP assessment is anchored in validated assays. The objective clinical picture is built on the VALIDATED tier.
2. Use emerging tests as support, labeled as such. Emerging tests add texture; they do not carry a diagnosis alone.
3. Contested tests never stand alone. ADJUNCTIVE/CONTESTED tests may inform clinical reasoning but never independently justify an intervention. A clinical decision rests on validated data integrated with the clinical picture.
4. Provoked urine metal testing, specifically, is acknowledged as contested. Where used, it is used transparently, with the patient informed of the controversy, and never as the sole justification for mobilization or chelation.
5. Disclose test status to the patient. Patients are told which tier a given test occupies.
6. Let the data decide. The NAP Outcome Registry tracks which tests actually predict outcomes. Over time, a test earns or loses its tier on the basis of NAP's own evidence, not assertion.

This standard is not a retreat from the tests integrative practitioners value. It is the discipline that lets NAP use them credibly — by being the first to say, clearly, which ones are proven and which ones are not.

OVERALL CALIBRATION

What The Evidence Establishes

The foundational claims of the NAP framework are supported by peer reviewed research at varying strength levels across the territories surveyed. The eight biological systems framework reflects documented biological reality. The seven dysfunction categories each represent peer reviewed bodies of evidence. The cumulative exposure perspective reflects current toxicological consensus. The developmental origins perspective reflects three decades of established research. The convergence of medical disciplines toward integrated systems based practice reflects current clinical evolution. The framework presented in The NAP Manifesto represents a synthesis of established evidence across multiple disciplines into a unified clinical paradigm.

What The Evidence Qualifies

The integrated cascade architecture, in which all eight biological systems and all seven dysfunction categories interact as a unified clinical system in any individual patient, requires further direct testing in prospective clinical research. The framework is biologically plausible and supported at the individual link level but has not been comprehensively tested as a unified hypothesis. The clinical effectiveness of comprehensive multi-domain NAP protocols compared to single intervention approaches will be established through outcome data collection across accredited NAP Centers as the category matures. Specific clinical applications including condition specific protocols, ingredient and intervention specific evidence, and population specific applications will be supported by separate evidence appendices that complement this foundational document. The comprehensive evidence architecture for the full NAP Standards Library will be developed progressively as the category matures and as the research program generates additional outcome data.

Research Priorities for the NAP Standards Council

Priority research partnerships for the next decade include the following.

1. Prospective clinical validation of the integrated cascade architecture through comprehensive biomarker and functional outcome tracking in patients receiving NAP protocols, in partnership with academic medical centers across multiple geographic regions.

2. Comparative effectiveness research comparing NAP protocols to standard care for specific clinical conditions where the underlying terrain restoration approach is hypothesized to produce superior outcomes.

3. Long term outcome studies of structured de prescribing in populations transitioning from pharmaceutical management to NAP protocols, comparing outcomes to continued pharmaceutical management.

4. Cost effectiveness analysis comparing NAP protocols to conventional first line care across multiple clinical conditions, supporting policy and payment integration.

5. Validation studies of the eight systems and seven dysfunction categories framework as clinically actionable diagnostic categories, including development of standardized assessment instruments and validation across diverse populations.

6. Population specific application studies validating the universal NAP framework across diverse demographic groups including age, sex, geographic region, occupation, and condition specific contexts.

7. Mechanism studies of integrated nutraceutical and botanical protocols, building on the substantial single agent research base toward understanding combined and sequenced intervention effects.

CONCLUSION

The NAP framework presented in The NAP Manifesto is a clinical paradigm supported, system by system, dysfunction by dysfunction, by peer reviewed research that is publicly available and independently verifiable. The framework represents the synthesis of multiple independent research streams converging toward an integrated understanding of human health and disease. The evidence in this compendium establishes that the biological substrate driving the chronic disease epidemic of modern populations is identifiable, measurable, and addressable through interventions the NAP framework organizes and deploys. The pharmaceutical first model of chronic disease management has been tested across decades and is producing inadequate population health outcomes despite substantial resource expenditure. The evidence in this compendium establishes that an integrated terrain restoration paradigm reflects the actual biology of human health and disease and offers measurable improvements over single agent pharmaceutical management for many populations and conditions. The question is no longer whether a new clinical architecture is warranted. The question is whether the institutional and political will exists to build it at the scale the moment requires. The cultural readiness for paradigm change has reached critical mass. The scientific evidence has matured. The technological infrastructure for global delivery exists. What remains is execution. This document is the evidentiary foundation upon which that execution proceeds. The NAP Standards Council commits to maintaining this compendium as a living reference, updating it as research advances, correcting it where findings require correction, and using it as the transparent evidentiary foundation for every clinical protocol, credentialing standard, legislative engagement, and coalition activity that the NAP movement undertakes. This is the standard of evidence to which a founding global clinical category must hold itself. This is the standard we commit to.

Compiled and Published by The NAP Standards Council Founder and Inaugural Chair Michael Andrew Feller Jones

APPENDIX: CONSOLIDATED CITATION LIST

The following is a consolidated list of primary sources cited in this Evidence Compendium, organized by research territory. All citations point to peer reviewed publications, authoritative reports from international or governmental scientific bodies, or major professional medical organization scientific statements. PubMed identifiers and PMC numbers are provided where available.

Systems Biology and Integrated Function

• Cryan JF, et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews.
• Mayer EA, et al. (2014). Gut microbes and the brain: paradigm shift in neuroscience. Journal of Neuroscience.
• Reichlin S (1993). Neuroendocrine-immune interactions. New England Journal of Medicine.
• Hotamisligil GS (2017). Inflammation, metaflammation and immunometabolic disorders. Nature.
• Heneka MT, et al. (2015). Neuroinflammation in Alzheimer's disease. Lancet Neurology.
• Hyman M (2018). Functional medicine: an operating system for integrative health. JAMA.
• Beidelschies M, et al. (2019). Functional Medicine Model of Care and Quality-of-Life Outcomes. JAMA Network Open.

Environmental Toxin Burden

• CDC National Center for Environmental Health. National Report on Human Exposure to Environmental Chemicals.
• Woodruff TJ, et al. (2011). Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environmental Health Perspectives.
• Gore AC, et al. (2015). EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews.
• Landrigan PJ, et al. (2018). The Lancet Commission on pollution and health. Lancet.
• Sexton K, Hattis D (2007). Assessing cumulative health risks from exposure to environmental mixtures. Environmental Health Perspectives. PMC1867955.
• Mixture toxicity revisited: A translational review (2025). Toxicology.
• Cumulative Risk Assessment: An Overview (2012). PMC3315252.
• Cumulative Health Risk from Exposure Load (CHREL) (2024). PubMed PMID 39341379.
• Goldman SM, et al. (2023). Trichloroethylene exposure and Parkinson's disease risk in a contaminated water cohort. JAMA Neurology.
• U.S. Environmental Protection Agency (2024). PFAS National Primary Drinking Water Regulation (first enforceable national limits; MCLG = 0).
• International Agency for Research on Cancer. Benzene. IARC Monographs (Group 1 carcinogen). American Cancer Society, Benzene and cancer risk.

Heavy Metal Neurotoxicity

• Metal toxicity in the central nervous system. Environmental Health Perspectives. PMC1474439.
• Exposure to heavy metals and neurocognitive function in adults: a systematic review (2024). Environmental Sciences Europe.
• Co-exposure to lead, mercury, and cadmium induces neurobehavioral impairments (2023). Frontiers in Public Health. PMC10662100.
• Co-exposure to low-dose lead, cadmium, and mercury promotes memory deficits via dendritic spine pruning (2023). ScienceDirect.

Nutrient Status and Insufficiency

• DiNicolantonio JJ, et al. (2018). Subclinical magnesium deficiency: a principal driver of cardiovascular disease. Open Heart.
• Holick MF (2017). The vitamin D deficiency pandemic. Reviews in Endocrine and Metabolic Disorders.
• Costello R, et al. (2016). Perspective: Evidence-Based Reference Interval for Serum Magnesium. Advances in Nutrition.
• Simopoulos AP (2016). An Increase in the Omega-6/Omega-3 Fatty Acid Ratio. Nutrients.
• Lewis MD, et al. (2011). Suicide Deaths and Omega-3 Fatty-Acid Status. Journal of Clinical Psychiatry. PubMed PMID 21903029.
• Mocking RJT, et al. (2016). Meta-analysis of omega-3 supplementation for depression. Translational Psychiatry.
• Pludowski P, et al. (2018). Vitamin D supplementation guidelines. Journal of Steroid Biochemistry.

Microbiome and Gut Function

• Gilbert JA, et al. (2018). Current understanding of the human microbiome. Nature Medicine.
• Sonnenburg ED, Sonnenburg JL (2019). The ancestral and industrialized gut microbiota. Nature Reviews Microbiology.
• Mesnage R, Antoniou MN (2020). Computational modelling of glyphosate effects on the gut microbiome. Current Research in Toxicology.
• Fasano A (2020). All disease begins in the (leaky) gut. F1000Research.
• Camilleri M (2019). Leaky gut: mechanisms, measurement and clinical implications. Gut.
• Aronson NE, et al. (2006). In harm's way: infections in deployed military forces. Clinical Infectious Diseases.

Mitochondrial and Metabolic Function

• Picard M, et al. (2018). Mitochondrial functions and stress responses. Proceedings of the National Academy of Sciences.
• Wallace DC (2018). Mitochondrial genetic medicine. Nature Genetics.
• Goodpaster BH, Sparks LM (2017). Metabolic Flexibility in Health and Disease. Cell Metabolism.
• Hern\xE1ndez-Camacho JD, et al. (2018). Coenzyme Q10 Supplementation. Frontiers in Physiology.
• Verdin E (2015). NAD+ in aging, metabolism, and neurodegeneration. Science.

Hormonal Health

• Diamanti-Kandarakis E, et al. (2009). Endocrine-Disrupting Chemicals: Endocrine Society Statement. Endocrine Reviews.
• Travison TG, et al. (2007). A population-level decline in serum testosterone levels. Journal of Clinical Endocrinology and Metabolism.
• Lokeshwar SD, et al. (2021). Decline in serum testosterone in young men. European Urology Focus.
• Manson JE, et al. (2017). Menopause Management. New England Journal of Medicine.
• Stuenkel CA, et al. (2015). Treatment of Symptoms of the Menopause: Endocrine Society Guideline. JCEM.
• McEwen BS (2017). Neurobiological and Systemic Effects of Chronic Stress. Chronic Stress.
• Garber JR, et al. (2012). Clinical practice guidelines for hypothyroidism. Endocrine Practice.

Neurological and Psychiatric

• Miller AH, Raison CL (2016). The role of inflammation in depression. Nature Reviews Immunology.
• Mojtabai R, et al. (2014). National trends in long-term use of antidepressant medications. Journal of Clinical Psychiatry.
• Long-term Psychoactive Medications and Risk of Suicide and Overdose Death (2022). Journal of General Internal Medicine. PubMed PMID 36042093.
• Morin R, et al. (2020). High-Risk Medication Use and Polypharmacy. Innovation in Aging.
• Sarris J, et al. (2015). Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry.

Immune and Inflammatory

• Franceschi C, et al. (2018). Inflammaging. Nature Reviews Endocrinology.
• Lerner A, et al. (2015). World Incidence and Prevalence of Autoimmune Diseases. International Journal of Celiac Disease.
• Calder PC (2020). Nutrition, immunity and COVID-19. BMJ Nutrition, Prevention and Health.
• Aranow C (2011). Vitamin D and the Immune System. Journal of Investigative Medicine.
• Belkaid Y, Hand TW (2014). Role of the microbiota in immunity and inflammation. Cell.
• Round JL, Mazmanian SK (2009). The gut microbiota shapes intestinal immune responses. Nature Reviews Immunology.

Cardiovascular and Metabolic

• Ridker PM, et al. (2017). Antiinflammatory Therapy with Canakinumab. New England Journal of Medicine. CANTOS trial.
• Cromwell WC, et al. (2007). LDL Particle Number and Risk. Journal of Clinical Lipidology.
• Saklayen MG (2018). Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports.
• Bhatt DL, et al. (2019). Cardiovascular Risk Reduction with Icosapent Ethyl. NEJM. REDUCE-IT.
• Hruby A, et al. (2014). Magnesium intake and risk of type 2 diabetes. Diabetes Care.

Structural and Musculoskeletal

• Weaver CM, et al. (2016). Calcium plus vitamin D supplementation and fractures. Osteoporosis International.
• Cruz-Jentoft AJ, et al. (2019). Sarcopenia: revised European consensus. Age and Ageing.
• Phillips SM, et al. (2016). Protein 'requirements' beyond the RDA. Applied Physiology, Nutrition, and Metabolism.
• Tick H, et al. (2018). Evidence-Based Nonpharmacologic Strategies for Comprehensive Pain Care. Explore.
• Hilton L, et al. (2017). Mindfulness Meditation for Chronic Pain. Annals of Behavioral Medicine.

Developmental Origins of Health and Disease

• Nobile S, et al. (2022). Perinatal Origins of Adult Disease. Journal of Personalized Medicine. PMC8877993.
• Bezek S, et al. (2010). Developmental origin of chronic diseases. PMC2993479.
• Pinson MR, et al. (2021). Extracellular Vesicles in Premature Aging and Diseases. PMC8407878.
• Heindel JJ, et al. (2015). Developmental Origins: Integrating Environmental Influences. Endocrinology.
• Rasmussen MA, et al. (2020). Mode of delivery and microbiome composition. Nature Communications.
• Victora CG, et al. (2016). Breastfeeding in the 21st century. Lancet.
• Felitti VJ, et al. (1998). Adverse Childhood Experiences. American Journal of Preventive Medicine.
• Shonkoff JP, et al. (2012). The lifelong effects of early childhood adversity. Pediatrics.

Convergence of Medical Disciplines

• Lake J (2015). The integrative management of PTSD. Mental Health Clinician.
• Lianov L, Johnson M (2010). Physician competencies for prescribing lifestyle medicine. JAMA.
• Barab\xE1si AL, et al. (2011). Network medicine. Nature Reviews Genetics.
• Hood L, et al. (2015). Systems biology and P4 medicine. Rambam Maimonides Medical Journal. This compendium commits to regular revision as new research publishes. Practitioners, researchers, and academic partners are invited to submit additional citations and proposed revisions through the NAP Standards Council for review and incorporation into future versions.

INTEGRATION NOTE

This edition integrates verified findings from the companion research program developed for the book on the veteran biological cascade and its consolidated source trail of primary literature. The integration follows three rules, consistent with this Compendium's standing evidence discipline.

1. Primary source tracing. Every statistic added in this edition traces to a named primary source, a peer reviewed study, an authoritative governmental or international scientific body, or a major professional organization statement, not to a secondary paraphrase.
2. Calibration preserved. Associations are labeled as associations. Where an integrated finding could be over read, a CALIBRATION note narrows the claim to what the evidence supports. One addition, in Territory Seven, explicitly corrects a popular over claim, on the principle that the framework's credibility depends on following the evidence even when it contradicts a favored narrative.
3. Population scope maintained. This Compendium remains an all population document. Military exposure specific findings developed in the companion research, including open burn pits, contaminated installation water, PFAS on military installations, K2, Qarmat Ali hexavalent chromium, mefloquine, and atomic veteran radiation, are routed to the NAP Veteran Health Specialty Track, where the population context is appropriate. The universal toxicology those cohorts demonstrate is retained here.

Sources marked (format at publication) are landmark references whose final citation formatting is completed at typesetting, consistent with the living reference practice stated above.

Additional Sources Integrated

Systems Biology and Integrated Function

• Barnett K, et al. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education. Lancet.
• McEwen BS (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine.

Detoxification and Environmental Toxin Burden

• Goldman SM, et al. (2023). Trichloroethylene exposure and Parkinson's disease risk in a contaminated water cohort. JAMA Neurology.
• U.S. Environmental Protection Agency (2024). PFAS National Primary Drinking Water Regulation (first enforceable national limits; MCLG = 0).
• International Agency for Research on Cancer. Benzene (Group 1 carcinogen). IARC Monographs; American Cancer Society.

Nutrient Status and Insufficiency

• Lewis MD, et al. (2011). Suicide deaths of active-duty US military and omega-3 fatty acid status: a case-control comparison. Journal of Clinical Psychiatry.

Microbiome and Gut Function

• Fasano A (2011). Zonulin and its regulation of intestinal barrier function. Physiological Reviews.
• David LA, et al. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature.

Hormonal Health

• Leproult R, Van Cauter E (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA.

Neurological and Psychiatric

• Westphal Filho FL, et al. (2025). Statin use and dementia risk: systematic review and meta-analysis. Alzheimer's & Dementia: Translational Research & Clinical Interventions.

Immune and Inflammatory

• Ridker PM, et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease (CANTOS). New England Journal of Medicine.

Cardiovascular and Metabolic

• Libby P (2021). Inflammation in atherosclerosis: from pathophysiology to practice (and Libby P, 2002, Nature).

Convergence of Medical Disciplines

• U.S. Department of Veterans Affairs. Whole Health system and complementary and integrative health modalities.

Representative reviews cited in territory and finalized at publication: adult neuroplasticity (Territory Seven); inflammaging (Territory Eight); skeletal muscle myokine biology (Territory Ten).